MCC-18-LUN-107-PMC: Phase II Study of Combination Rucaparib With Nivolumab in Platinum Sensitive Small Cell Lung Carcinoma Patients as Maintenance After Induction Therapy with Platinum Doublet

Grants and Contracts Details

StatusActive
Effective start/end date7/23/191/17/23

Funding

  • Clovis Oncology Incorporated: $119,000.00